Replica (CoEHAR): is there any correlation between Covid-19 and Harm Reduction?

A new study by CoEHAR, the "Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model" investigates the molecular mechanisms that regulate the expression of the ACE2 enzyme, involved in Covid-19 infection

Continue ReadingReplica (CoEHAR): is there any correlation between Covid-19 and Harm Reduction?

Replica Project: a new study sets quality standards for the storage conditions of nicotine samples

The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products

Continue ReadingReplica Project: a new study sets quality standards for the storage conditions of nicotine samples

Latest study by CoEHAR aims to systematically review all the studies on health effects of e-cigarette substitution

The main goal of the protocol, the research project plan, is to examine the scientific evidence on the effects of e-cigarettes on smokers from the available studies. The project includes writing a paper for doctors and health care providers, a fact sheet for people who use e-cigarettes, and a policy brief for legislators on health committees

Continue ReadingLatest study by CoEHAR aims to systematically review all the studies on health effects of e-cigarette substitution

CoEHAR- The risk of Covid-19 transmission with vaping is negligible, equal to 1%

According to the latest study by COEHAR laboratories within the University of Catania, conducted by a group coordinated by Professor Riccardo Polosa, the risk of Covid-19 transmission with vaping is negligible, equal to 1%

Continue ReadingCoEHAR- The risk of Covid-19 transmission with vaping is negligible, equal to 1%